Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other financing activities (2016 - 2025)

Historic Other financing activities for Haemonetics (HAE) over the last 15 years, with Q4 2025 value amounting to -$14000.0.

  • Haemonetics' Other financing activities changed N/A to -$14000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$89000.0, marking a year-over-year decrease of 10037.28%. This contributed to the annual value of $23.1 million for FY2025, which is 3179178.08% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Other financing activities is -$14000.0.
  • Haemonetics' 5-year Other financing activities high stood at $23.1 million for Q2 2024, and its period low was -$863000.0 during Q3 2023.
  • For the 5-year period, Haemonetics' Other financing activities averaged around $2.5 million, with its median value being -$9000.0 (2021).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 1266666.67% in 2022, then crashed by 653846.15% in 2023.
  • Haemonetics' Other financing activities (Quarter) stood at -$9000.0 in 2021, then skyrocketed by 12666.67% to $1.1 million in 2022, then tumbled by 95.23% to $54000.0 in 2023, then soared by 42742.59% to $23.1 million in 2024, then plummeted by 100.06% to -$14000.0 in 2025.
  • Its last three reported values are -$14000.0 in Q4 2025, -$39000.0 for Q3 2025, and -$36000.0 during Q2 2025.